Nurix Therapeutics, Inc.
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY
Last updated:
Abstract:
The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Status:
Application
Type:
Utility
Filling date:
4 Feb 2020
Issue date:
12 May 2022